期刊文献+

心肌淀粉样变性的MRI与超声心动图诊断价值 被引量:5

MRI and echocardiography in the diagnosis of cardiac amyloidosis
原文传递
导出
摘要 目的 探讨心肌淀粉样变性的MRI与超声心动图诊断价值.方法 回顾性分析11例经病理活检证实的心肌淀粉样变性患者的MR和超声心动图检查结果.结果 MRI和超声心动图示心肌淀粉样变性患者中,11例均存在不同程度的左心室、室间隔轻度增厚,5例房间隔轻度增厚,7例左心室心肌质量增加,7例左心房增大,6例左心室射血分数减低,10例舒张功能减低,多伴随心包积液、胸腔积液.8例MRI延迟增强显示特征性的弥漫性、广泛性心内膜下至透壁性延迟强化.6例超声心动图显示心肌回声增强,呈磨玻璃样改变,并可见散在颗粒样斑点状强回声.结论 超声心动图具有较好的初步诊断价值,延迟增强MRI能为心肌淀粉样变性诊断及鉴别诊断提供更为全面、丰富的信息. Objective To assess the values of MRI and echocardiography for the diagnosis of cardiac amyloidosis (CA). Methods Eleven cases with CA proved pathologically performed MRI and echocardiography, the findings were analyzed retrospectively. Results The characteristic features of cardiac amyloidosis on MRI and echocardiography were:diffuse slight myocardial thickening of the left ventricular wall and interventricular septum (11 cases ), slight myocardial thickening of the interatrial septum (5 cases), increased left ventricular mass (7 cases), enlarged left atrium ( 7 cases), impaired ventricular systolic and diastolic function (10 cases ), pleural and pericardial effusions (11 and 9 cases ).Echocardiography showed that myocardium was hyperechoic and presented as ground glass with some spotty hyperechoes in 6 cases. MRI revealed a distinct diffuse delayed enhancement of subendocardial and entire myocardium in 8 cases. Conclusion Doppler echocardiography is the first-choice imaging technique and cardiac magnetic resonance imaging can provide more information for the diagnosis of CA.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2010年第9期907-911,共5页 Chinese Journal of Radiology
关键词 心肌疾病 磁共振成像 超声心动描记术 Cardiomyopathies Magnetic resonance imaging Echocardiography
  • 相关文献

参考文献19

  • 1孟磊,丁文惠,史力斌,龚艳君,刘兆平.免疫球蛋白轻链型淀粉样变性病心脏受累的临床特征及预后[J].中华心血管病杂志,2007,35(4):340-343. 被引量:10
  • 2曾勇,朱文玲,方理刚,郭丽琳,倪超.心脏淀粉样变的临床表现及诊断回顾分析[J].中华内科杂志,2000,39(2):91-93. 被引量:17
  • 3Vanden Driesen RI,Slaughter RE,Strugnell WE.MR findings in cardiac amyloidosis.A JR,2006,186:1682-1685.
  • 4Dubrey SW,Cha K,Anderson J,et al.The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.QJM,1998,91:141-157.
  • 5Maceira AM,Joshi J,Prasad SK,et al.Cardiovascular magnetic resonance in cardiac amyloidosis.Circulation,2005,111:186-193.
  • 6Falk RH.Diagnosis and management of the cardiac amyloidoses.Circulation,2005,112:2047-2060.
  • 7Bogaert J,Dymarkowski S,Taylor AM.Clinical cardiac MR.New York:Springer-Verlag,2005:234-238.
  • 8Kwong RY,Falk RH.Cardiovascular magnetic resonance in cardiac amyloidosis.Circulation,2005,111:122-124.
  • 9Aerts JG,Tan KY,Veerhoek M,et al.Pleural amyloidosis as a cause of excessive pleural effusions.Ned Tijdschr Geneeskd,1999,143:104-106.
  • 10HigginsCB,DeRoosA.心血管MRI和MRA.郑州:河南科学技术出版社,2008:338-339.

二级参考文献32

  • 1颜彦,杨茗,朱文青,沈成兴,葛均波.原发性淀粉样变累及心脏三例[J].中华心血管病杂志,2004,32(5):463-463. 被引量:5
  • 2林静娜,孙静平,杨兴生.淀粉样变心肌病[J].中国医刊,2006,41(2):49-51. 被引量:8
  • 3张莉华.具有“留守经历”大学生的心理分析[J].当代青年研究,2006(12):28-30. 被引量:93
  • 4Wood MJ, Picard MH. Utility of echocardiography in the evaluation of individuals with cardiomyopathy. Heart, 2004,917:707-712.
  • 5Bellavia D, Abraham TP, Pellikka PA, et al. Dectection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography.J Am Soc Echocardiogr, 2007, 20:1194- 1202.
  • 6Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol, 2008,51 : 1022-1030.
  • 7Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol,1985,6:737-743.
  • 8马文珠,张寄南.心肌疾病.第2版.南京:江苏科学技术出版社,2001:238-241.
  • 9Tel C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol, 1996,28 : 658-664.
  • 10McCarthy RE, Kasper EK. A review of the amyloidoses that infiltrate the heart. Clin Cardiol, 1998,21:547-552.

共引文献41

同被引文献65

  • 1马爱群,吴格如.心脏淀粉样变性诊断与治疗(附病例介绍与分析)[J].中华心血管病杂志,2006,34(12):1150-1152. 被引量:18
  • 2Rapezzi C,Merlini G,Quarta CC,et al.Systemic cardiac amyloidoses:disease profiles and clinical courses of the 3 main types.Circulation,2009,120:1203-1212.
  • 3Maceira AM,Joshi J,Prasad SK,et al.Cardiovascular magnetic resonance in cardiac amyloidosis.Circulation,2005,111:186-193.
  • 4Vogelsberg H,Malhrholdt H,Deluigi CC,et al.Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis:noninvasive imaging compared to endomyocardial biopsy.J Am Coll Cardiol,2008,51:1022-1030.
  • 5Austin BA,Tang WH,Rodriguez ER,et al.Delayed hyperenhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.JACC Cardiovasc Imaging,2009,2:1369-1377.
  • 6Ruberg FL,Appelbaum E,Davidoff R,et al.Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.Am J Cardiol,2009,103:544-549.
  • 7Syed IS,Glockner JF,Feng D,et al.Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.JACC Cardiovasc Imaging,2010,3:155-164.
  • 8Sanchorawala V,Wright DG,Seldin DC,et al.An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.Bone Marrow Transplant,2001,28:637-642.
  • 9Cheng Z,Kang L,Tian Z,et al.Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.Ann Noninvasive Electrocardiol,2011,16:25-29.
  • 10Mahrholdt H,Wagner A,Judd RM,et al.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Eur Heart J,2005,26:1461-1474.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部